{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T01:52:34Z","timestamp":1791078754186,"version":"4.1.0"},"reference-count":58,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Long-term effects of risedronate on bone mineral maturity\/crystallinity and collagen cross-link ratio in triple iliac crest biopsies of osteoporotic women were evaluated. In this double-blinded study, 3- and 5-year treatment with risedronate arrested the tissue aging encountered in untreated osteoporosis and in osteoporosis treated with other antiresorptives. This effect may be contributing to risedronate's antifracture efficacy.<\/jats:p>\n               <jats:p>Introduction: Risedronate is widely used in the treatment of osteoporosis. It reduces bone turnover, increases BMD, and decreases fracture risk. To date, there are no data available on the long-term effects of risedronate on bone material properties in humans.<\/jats:p>\n               <jats:p>Materials and Methods: Osteoporotic women enrolled in the VERT-NA trial received either risedronate (5 mg\/day, orally) or placebo for up to 5 years. All subjects received calcium. They also received vitamin D supplementation if deficient at baseline. Triple iliac crest biopsies were collected from a subset of these subjects at baseline, 3 years, and 5 years. Mineral maturity\/crystallinity and collagen cross-link ratio was measured in these biopsies using Fourier transform infrared imaging.<\/jats:p>\n               <jats:p>Results: Patients that received placebo exhibited increased mineral maturity\/crystallinity and collagen cross-link ratio after 3 and 5 years compared with baseline values. On the contrary, patients that received risedronate retained baseline values in both bone material indices throughout. A more spatially detailed analysis revealed that this was achieved mainly through beneficial effects on active bone-forming areas. Surprisingly, patients that received risedronate achieved premenopausal values at bone-forming areas in both indices after 5 years of treatment.<\/jats:p>\n               <jats:p>Conclusion: Long-term treatment with risedronate affects bone material properties (mineral maturity\/crystallinity and collagen cross-link ratio) and arrests the tissue aging apparent in untreated osteoporosis. These changes at the material level of the bone matrix may contribute to risedronate's rapid and sustained antifracture efficacy in osteoporotic patients.<\/jats:p>","DOI":"10.1359\/jbmr.060701","type":"journal-article","created":{"date-parts":[[2006,9,22]],"date-time":"2006-09-22T16:14:14Z","timestamp":1158941654000},"page":"1581-1590","source":"Crossref","is-referenced-by-count":112,"title":["Bone Material Properties in Trabecular Bone From Human Iliac Crest Biopsies After 3- and 5-Year Treatment With Risedronate"],"prefix":"10.1093","volume":"21","author":[{"given":"Erich","family":"Durchschlag","sequence":"first","affiliation":[{"name":"Ludwig Boltzmann Institute of Osteology at the Hanusch Hospital WGKK and AUVA Trauma Centre Meidling, 4th Medical Department, Hanusch Hospital, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleftherios P","family":"Paschalis","sequence":"additional","affiliation":[{"name":"Ludwig Boltzmann Institute of Osteology at the Hanusch Hospital WGKK and AUVA Trauma Centre Meidling, 4th Medical Department, Hanusch Hospital, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Zoehrer","sequence":"additional","affiliation":[{"name":"Ludwig Boltzmann Institute of Osteology at the Hanusch Hospital WGKK and AUVA Trauma Centre Meidling, 4th Medical Department, Hanusch Hospital, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Roschger","sequence":"additional","affiliation":[{"name":"Ludwig Boltzmann Institute of Osteology at the Hanusch Hospital WGKK and AUVA Trauma Centre Meidling, 4th Medical Department, Hanusch Hospital, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Fratzl","sequence":"additional","affiliation":[{"name":"Department of Biomaterials, Max Planck Institute of Colloids and Interfaces, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Recker","sequence":"additional","affiliation":[{"name":"Osteoporosis Research Center, Creighton University, Omaha, Nebraska, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Phipps","sequence":"additional","affiliation":[{"name":"Procter & Gamble Pharmaceuticals, Mason, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Klaushofer","sequence":"additional","affiliation":[{"name":"Ludwig Boltzmann Institute of Osteology at the Hanusch Hospital WGKK and AUVA Trauma Centre Meidling, 4th Medical Department, Hanusch Hospital, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2009,12,4]]},"reference":[{"key":"2024013021125158300_bib1","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1039\/B402005G","article-title":"Structure and mechanical quality of the collagen-mineral composite in bone","volume":"14","author":"Fratzl","year":"2004","journal-title":"J Mater Chem"},{"key":"2024013021125158300_bib2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1359\/jbmr.2000.15.2.183","article-title":"Bone matters: Are density increases necessary to reduce fracture risk","volume":"15","author":"Faulkner","year":"2000","journal-title":"J Bone Miner Res"},{"key":"2024013021125158300_bib3","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s002239900370","article-title":"Unraveling the role of structure and density in determining vertebral bone strength","volume":"61","author":"Veenland","year":"1997","journal-title":"Calcif Tissue Int"},{"key":"2024013021125158300_bib4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1359\/jbmr.2000.15.1.24","article-title":"Determinants of bone loss from the femoral neck in women of different ages","volume":"15","author":"Melton","year":"2000","journal-title":"J Bone Miner Res"},{"key":"2024013021125158300_bib5","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/bmj.312.7041.1254","article-title":"Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures","volume":"312","author":"Marshall","year":"1996","journal-title":"BMJ"},{"key":"2024013021125158300_bib6","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0002-9343(85)90343-2","article-title":"Are patients with hip fractures more osteoporotic? Review of the evidence","volume":"78","author":"Cummings","year":"1985","journal-title":"Am J Med"},{"key":"2024013021125158300_bib7","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.288.15.1889","article-title":"Clinical use of bone densitometry: Scientific review","volume":"288","author":"Cummings","year":"2002","journal-title":"JAMA"},{"key":"2024013021125158300_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1359\/jbmr.2002.17.1.1","article-title":"Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy","volume":"17","author":"Sarkar","year":"2002","journal-title":"J Bone Miner Res"},{"key":"2024013021125158300_bib9","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1385\/JCD:7:3:255","article-title":"Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate: Greater increases in bone mineral density do not relate to greater decreases in fracture risk","volume":"7","author":"Watts","year":"2004","journal-title":"J Clin Densitom"},{"key":"2024013021125158300_bib10","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1359\/JBMR.050814","article-title":"Relationship between changes in BMD and nonvertebral fracture incidence associated with risedronate: Reduction in risk of nonvertebral fracture is not related to change in BMD","volume":"20","author":"Watts","year":"2005","journal-title":"J Bone Miner Res"},{"key":"2024013021125158300_bib11","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jama.282.14.1344","article-title":"Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: A randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group","volume":"282","author":"Harris","year":"1999","journal-title":"JAMA"},{"key":"2024013021125158300_bib12","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1359\/jbmr.2002.17.7.1139","article-title":"Risedronate preserves trabecular architecture and increases bone strength in vertebra of ovariectomized minipigs as measured by three-dimensional microcomputed tomography","volume":"17","author":"Borah","year":"2002","journal-title":"J Bone Miner Res"},{"key":"2024013021125158300_bib13","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.bone.2003.12.013","article-title":"Risedronate preserves bone architecture in postmenopausal women with osteoporosis as measured by three-dimensional microcomputed tomography","volume":"34","author":"Borah","year":"2004","journal-title":"Bone"},{"key":"2024013021125158300_bib14","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S8756-3282(02)00869-4","article-title":"Effects of long-term risedronate on bone quality and bone turnover in women with postmenopausal osteoporosis","volume":"31","author":"Eriksen","year":"2002","journal-title":"Bone"},{"key":"2024013021125158300_bib15","doi-asserted-by":"crossref","first-page":"202","DOI":"10.4158\/EP.8.3.202","article-title":"Response of bone mineral density to once-weekly administration of risedronate","volume":"8","author":"Gordon","year":"2002","journal-title":"Endocr Pract"},{"key":"2024013021125158300_bib16","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00223-004-0039-7","article-title":"Five years of treatment with risedronate and its effects on bone safety in women with postmenopausal osteoporosis","volume":"75","author":"Ste-Marie","year":"2004","journal-title":"Calcif Tissue Int"},{"key":"2024013021125158300_bib17","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1210\/jc.2002-020400","article-title":"Risedronate prevents new vertebral fractures in postmenopausal women at high risk","volume":"88","author":"Watts","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2024013021125158300_bib18","first-page":"109","article-title":"Infrared microspectroscopic imaging of biomineralized tissues using a mercury-cadmium-telluride focal-plane array detector","volume":"44","author":"Marcott","year":"1998","journal-title":"Cell Mol Biol"},{"key":"2024013021125158300_bib19","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1117\/1.429916","article-title":"Infrared spectroscopy, microscopy, and microscopic imaging of mineralizing tissues. Spectra-structure correlations from human iliac crest biopsies","volume":"4","author":"Mendelsohn","year":"1999","journal-title":"J Biomed Opt"},{"key":"2024013021125158300_bib20","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1359\/jbmr.2001.16.10.1821","article-title":"Spectroscopic characterization of collagen cross-links in bone","volume":"16","author":"Paschalis","year":"2001","journal-title":"J Bone Miner Res"},{"key":"2024013021125158300_bib21","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s002239900371","article-title":"FTIR microspectroscopic analysis of normal human cortical and trabecular bone","volume":"61","author":"Paschalis","year":"1997","journal-title":"Calcif Tissue Int"},{"key":"2024013021125158300_bib22","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s002239900372","article-title":"FTIR microspectroscopic analysis of human iliac crest biopsies from untreated osteoporotic bone","volume":"61","author":"Paschalis","year":"1997","journal-title":"Calcif Tissue Int"},{"key":"2024013021125158300_bib23","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/BF00369214","article-title":"FTIR microspectroscopic analysis of human osteonal bone","volume":"59","author":"Paschalis","year":"1996","journal-title":"Calcif Tissue Int"},{"key":"2024013021125158300_bib24","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1359\/jbmr.2003.18.11.1942","article-title":"Distribution of collagen cross-links in normal human trabecular bone","volume":"18","author":"Paschalis","year":"2003","journal-title":"J Bone Miner Res"},{"key":"2024013021125158300_bib25","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1359\/jbmr.040820","article-title":"Bone fragility and collagen cross-links","volume":"19","author":"Paschalis","year":"2004","journal-title":"J Bone Miner Res"},{"key":"2024013021125158300_bib26","doi-asserted-by":"crossref","first-page":"4644","DOI":"10.1210\/jc.2004-2489","article-title":"Bone mineral and collagen quality in iliac crest biopsies of patients given teriparatide: New results from the Fracture Prevention Trial","volume":"90","author":"Paschalis","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2024013021125158300_bib27","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1359\/jbmr.2003.18.4.769","article-title":"Bone mineral and collagen quality in humeri of ovariectomized cynomolgus monkeys given rhPTH(1\u201334) for 18 months","volume":"18","author":"Paschalis","year":"2003","journal-title":"J Bone Miner Res"},{"key":"2024013021125158300_bib28","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1359\/jbmr.2003.18.6.955","article-title":"Effect of hormone replacement therapy on bone quality in early postmenopausal women","volume":"18","author":"Paschalis","year":"2003","journal-title":"J Bone Miner Res"},{"key":"2024013021125158300_bib29","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1359\/jbmr.1999.14.10.1768","article-title":"Intermittent and continuous administration of the bisphosphonate ibandronate in ovariohysterectomized beagle dogs: Effects on bone morphometry and mineral properties","volume":"14","author":"Monier-Faugere","year":"1999","journal-title":"J Bone Miner Res"},{"key":"2024013021125158300_bib30","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s00223-001-1016-z","article-title":"Optimal methods for processing mineralized tissues for Fourier transform infrared microspectroscopy","volume":"70","author":"Aparicio","year":"2002","journal-title":"Calcif Tissue Int"},{"key":"2024013021125158300_bib31","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S8756-3282(98)00112-4","article-title":"Validation of quantitative backscattered electron imaging for the measurement of mineral density distribution in human bone biopsies","volume":"23","author":"Roschger","year":"1998","journal-title":"Bone"},{"key":"2024013021125158300_bib32","first-page":"1","volume-title":"Methods of Calcified Tissue Preparation","author":"Schenk","year":"1984"},{"key":"2024013021125158300_bib33","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1021\/bi00465a022","article-title":"Protein secondary structures in water from second-derivative amide I infrared spectra","volume":"29","author":"Dong","year":"1990","journal-title":"Biochemistry"},{"key":"2024013021125158300_bib34","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1366\/0003702001950751","article-title":"IR microscopic imaging of pathological states and fracture healing of bone","volume":"54","author":"Mendelsohn","year":"2000","journal-title":"Appl Spectrosc"},{"key":"2024013021125158300_bib35","doi-asserted-by":"crossref","first-page":"5597","DOI":"10.1073\/pnas.0631609100","article-title":"Materials become insensitive to flaws at nanoscale: Lessons from nature","volume":"100","author":"Gao","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024013021125158300_bib36","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/S0006-3495(00)76426-5","article-title":"Mineralized collagen fibrils: A mechanical model with a staggered arrangement of mineral particles","volume":"79","author":"Jager","year":"2000","journal-title":"Biophys J"},{"key":"2024013021125158300_bib37","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/jbmr.5650091006","article-title":"Abnormal bone mineralization after fluoride treatment in osteoporosis: A small-angle x-ray-scattering study","volume":"9","author":"Fratzl","year":"1994","journal-title":"J Bone Miner Res"},{"key":"2024013021125158300_bib38","first-page":"127","volume-title":"Calcium and Phosphorus in Health and Disease","author":"Yamauchi","year":"1996"},{"key":"2024013021125158300_bib39","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1042\/bj2830129","article-title":"Identification of the loci of the collagen-associated Ehrlich chromogen in type I collagen confirms its role as a trivalent cross-link","volume":"283","author":"Kuypers","year":"1992","journal-title":"Biochem J"},{"key":"2024013021125158300_bib40","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1042\/bj3220535","article-title":"Chemistry of collagen cross-linking: Biochemical changes in collagen during the partial mineralization of turkey leg tendon","volume":"322","author":"Knott","year":"1997","journal-title":"Biochem J"},{"key":"2024013021125158300_bib41","first-page":"309","volume-title":"Osteoporosis 1987","author":"Dodds","year":"1987"},{"key":"2024013021125158300_bib42","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1042\/bj3101045","article-title":"Biochemical changes in the collagenous matrix of osteoporotic avian bone","volume":"310","author":"Knott","year":"1995","journal-title":"Biochem J"},{"key":"2024013021125158300_bib43","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S8756-3282(97)00279-2","article-title":"Collagen cross-links in mineralizing tissues: A review of their chemistry, function, and clinical relevance","volume":"22","author":"Knott","year":"1998","journal-title":"Bone"},{"key":"2024013021125158300_bib44","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0006-291X(92)91697-O","article-title":"Post-translational modifications in the collagen of human osteoporotic femoral head","volume":"185","author":"Bailey","year":"1992","journal-title":"Biochem Biophys Res Commun"},{"key":"2024013021125158300_bib45","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/03008209309014239","article-title":"Biochemical changes in the collagen of human osteoporotic bone matrix","volume":"29","author":"Bailey","year":"1993","journal-title":"Connect Tissue Res"},{"key":"2024013021125158300_bib46","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s002239900271","article-title":"Alteration in the extent of collagen I hydroxylation, isolated from femoral heads of women with a femoral neck fracture caused by osteoporosis","volume":"60","author":"Kowitz","year":"1997","journal-title":"Calcif Tissue Int"},{"key":"2024013021125158300_bib47","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1080\/03008200390223918","article-title":"Spectroscopically determined collagen Pyr\/deH-DHLNL cross-link ratio and crystallinity indices differ markedly in recombinant congenic mice with divergent calculated bone tissue strength","volume":"44","author":"Blank","year":"2003","journal-title":"Connect Tissue Res"},{"key":"2024013021125158300_bib48","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/jbmr.5650110214","article-title":"Effects of sodium fluoride and alendronate on the bone mineral in minipigs: A small-angle X-ray scattering and backscattered electron imaging study","volume":"11","author":"Fratzl","year":"1996","journal-title":"J Bone Miner Res"},{"key":"2024013021125158300_bib49","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1079\/BJN19940196","article-title":"Vitamin B6 deficiency experimentally-induced bone and joint disorder: Microscopic, radiographic and biochemical evidence","volume":"71","author":"Masse","year":"1994","journal-title":"Br J Nutr"},{"key":"2024013021125158300_bib50","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/8756-3282(96)00072-5","article-title":"Pyridoxine deficiency affects biomechanical properties of chick tibial bone","volume":"18","author":"Masse","year":"1996","journal-title":"Bone"},{"issue":"4 Suppl","key":"2024013021125158300_bib51","doi-asserted-by":"crossref","first-page":"365S","DOI":"10.1016\/8756-3282(95)00328-B","article-title":"Reduced concentrations of collagen cross-links are associated with reduced strength of bone","volume":"17","author":"Oxlund","year":"1995","journal-title":"Bone"},{"key":"2024013021125158300_bib52","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.bone.2005.05.003","article-title":"Novel insights into actions of bisphosphonates on bone: Differences in interactions with hydroxyapatite","volume":"38","author":"Nancollas","year":"2006","journal-title":"Bone"},{"issue":"Suppl 1","key":"2024013021125158300_bib53","first-page":"10","article-title":"Morphological studies of hydroxyapatite crystals exposed to disodium pamidronate","volume":"57","author":"Hein","year":"1997","journal-title":"Medicina (B Aires)"},{"key":"2024013021125158300_bib54","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3109\/07853899309147299","article-title":"Bisphosphonates in the treatment of metabolic bone diseases","volume":"25","author":"Rodan","year":"1993","journal-title":"Ann Med"},{"key":"2024013021125158300_bib55","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1177\/00220345880670121001","article-title":"The influence of high- and low-molecular-weight inhibitors on dissolution kinetics of hydroxyapatite and human enamel in lactate buffers: A constant composition study","volume":"67","author":"Budz","year":"1988","journal-title":"J Dent Res"},{"key":"2024013021125158300_bib56","first-page":"1185","article-title":"Comparative evaluation of three diphosphonates: In vitro adsorption (C- 14 labeled) and in vivo osteogenic uptake (Tc-99m complexed)","volume":"21","author":"Francis","year":"1980","journal-title":"J Nucl Med"},{"key":"2024013021125158300_bib57","author":"Romanello","year":"2006"},{"key":"2024013021125158300_bib58","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1124\/mol.105.011478","article-title":"Expression profiling of rat femur revealed suppression of bone formation genes by treatment with alendronate and estrogen but not raloxifene","volume":"68","author":"Helvering","year":"2005","journal-title":"Mol Pharmacol"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1359%2Fjbmr.060701","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/21\/10\/1581\/56483235\/5650211010.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/21\/10\/1581\/56483235\/5650211010.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T14:47:15Z","timestamp":1710341235000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/21\/10\/1581-1590\/7593240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10,1]]},"references-count":58,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2009,12,4]]},"published-print":{"date-parts":[[2006,10,1]]}},"URL":"https:\/\/doi.org\/10.1359\/jbmr.060701","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2006,10,1]]},"published":{"date-parts":[[2006,10,1]]}}}